Aurobindo Pharma Limited has informed the Exchange regarding a press release dated July 25, 2023, titled "Eugia Pharma receives USFDA Approval for Plerixafor Injection, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated July 25, 2023, titled "Eugia Pharma receives USFDA Approval for Plerixafor Injection, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial".